Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-02-13
1979-06-19
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 232306, 260112B, 424 12, G01N 3316, A61K 4300
Patent
active
041587030
ABSTRACT:
An improved T.sub.3 uptake test procedure characterized in that the separating agent employed therein comprises bovine serum albumin covalently coupled to a derivatized polysaccharide matrix by a bifunctional coupling agent selected from a group consisting of ##STR1## WHEREIN N IS AN INTEGER FROM 1 TO 6 AND WHEREIN E IS AN INTEGER FROM 1 TO 2.
A separating agent comprising bovine serum albumin covalently coupled to a derivatived polysaccharide matrix by a bifunctional coupling agent selected from a group consisting of ##STR2## WHEREIN N IS AN INTEGER FROM 1 TO 6 AND WHEREIN E IS AN INTEGER FROM 1 TO 2.
REFERENCES:
patent: 4081244 (1978-03-01), Polito et al.
patent: 4081245 (1978-03-01), Polito
patent: 4081246 (1978-03-01), Polito et al.
Beckman Instruments Inc.
Frieman Robert S.
Nucker Christine M.
Padgett Benjamin R.
Steinmeyer R. J.
LandOfFree
T.sub.3 uptake test employing covalently bound bovine serum albu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with T.sub.3 uptake test employing covalently bound bovine serum albu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and T.sub.3 uptake test employing covalently bound bovine serum albu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-56524